Ex Parte Johnson - Page 7


              Appeal No. 2006-0484                                                                Page 7                
              Application No. 09/657,729                                                                                

              necessarily indicates whether interaction has occurred and identifies the activity of the                 
              luciferase under specific redox conditions.  Thus, claims 1 and 51 reasonably appear to                   
              read on the method disclosed by Higgins.                                                                  
                     We affirm the rejection of claims 1 and 51 as anticipated by Higgins.  Appellant                   
              did not separately argue claims 2, 3, 5, 7, and 48-50.  Therefore, those claims fall with                 
              claim 1.  See 37 CFR § 41.37(c)(1)(vii).                                                                  
              3.  Anticipation by Weetall                                                                               
                     The examiner rejected claims 1-4, 6-10, 12, 13, 47, 49, and 50 under 35 U.S.C.                     
              § 102(b) as anticipated by Weetall.2  As the examiner pointed out, the methods                            
              disclosed by Weetall meet all the limitations of claim 1.  Example 1 is an immunoassay                    
              method in which magnetic particles coupled to an antibody to T4 is combined with (1) a                    
              sample of serum containing T4 and (2) T4 conjugated to glucose oxidase, on an                             
              electrode array.  Col. 3, lines 21-31.  After ten minutes’ incubation, a glucose solution is              
              added and the reaction mixture is placed into an apparatus “designed to supply a +0.40                    
              V potential between the working electrode and the counter electrode.”  Col. 3, lines 34-                  
              36 and 43-44.                                                                                             
                     In the apparatus, a magnet draws the magnetic beads, with attached antibody and                    
              T4-glucose oxidase conjugate or T4, to the working electrode at the bottom of the well.                   
              Then “[t]he voltage is applied and the current read in microamperes. . . . The more T4                    
              present in the sample, the less enzyme [glucose oxidase] bound to the working electrode                   
              through the first conjugate pair, and thus the less amperage.”  Col. 3, lines 50-53.                      


                                                                                                                        
              2 Weetall, U.S. Patent 4,963,245, issued October 16, 1990.                                                





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007